Page last updated: 2024-09-05

sb 203580 and farnesol

sb 203580 has been researched along with farnesol in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(farnesol)
Trials
(farnesol)
Recent Studies (post-2010) (farnesol)
3,48941,1371,1619404

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kabir, AN; Marber, MS; Mockridge, JW; Rakhit, RD; Saurin, A1

Other Studies

1 other study(ies) available for sb 203580 and farnesol

ArticleYear
Role of G proteins and modulation of p38 MAPK activation in the protection by nitric oxide against ischemia-reoxygenation injury.
    Biochemical and biophysical research communications, 2001, Sep-07, Volume: 286, Issue:5

    Topics: Adenoviridae; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Farnesol; GTP-Binding Proteins; Humans; Imidazoles; Ischemic Preconditioning, Myocardial; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Myocardium; Nitric Oxide; Organophosphonates; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Binding; Protein Isoforms; Protein Kinase C; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Time Factors

2001